Abstract
We describe here the identification and functional characterization of the enzyme O-GlcNAcase (OGA) as an RNA polymerase II elongation factor. Using in vitro transcription elongation assays, we show that OGA activity is required for elongation in a crude nuclear extract system, whereas in a purified system devoid of OGA the addition of rOGA inhibited elongation. Furthermore, OGA is physically associated with the known RNA polymerase II (pol II) pausing/elongation factors SPT5 and TRIM28-KAP1-TIF1β, and a purified OGA-SPT5-TIF1β complex has elongation properties. Lastly, ChIP-seq experiments show that OGA maps to the transcriptional start site/5′ ends of genes, showing considerable overlap with RNA pol II, SPT5, TRIM28-KAP1-TIF1β, and O-GlcNAc itself. These data all point to OGA as a component of the RNA pol II elongation machinery regulating elongation genome-wide. Our results add a novel and unexpected dimension to the regulation of elongation by the insertion of O-GlcNAc cycling into the pol II elongation regulatory dynamics.
Cite
CITATION STYLE
Resto, M., Kim, B. H., Fernandez, A. G., Abraham, B. J., Zhao, K., & Lewis, B. A. (2016). O-GlcNAcase is an RNA polymerase II elongation factor coupled to pausing factors SPT5 and TIF 1β. Journal of Biological Chemistry, 291(43), 22703–22713. https://doi.org/10.1074/jbc.M116.751420
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.